The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations is a research paper published in Molecular Oncology (2020). On theSindex it has a DataRank of 0.923. It has been cited 19 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.474
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Cancer Institute
Grant: R01CA197506
NCI NIH HHS
Grant: P30 CA033572
National Cancer Institute
Grant: NIH R01CA184585
National Cancer Institute
Grant: P30CA33572
NCI NIH HHS
Grant: R50 CA211280
NCI NIH HHS
Grant: R01 CA184585
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
National Institutes of Health
Grant: 5R01CA184585-03
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
National Institutes of Health
Grant: 5R01CA197506-04
Regulation of Single Strand Annealing Repair of Mammalian Chromosomal Breaks
National Institutes of Health
Grant: 5R50CA211280-05
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals